---
title: CS202210140_23
weight: 23
---
## Per_22 (CS202210140_23)
<b>Hierarchy: </b>
[CS202210140_465](https://purl.brain-bican.org/taxonomy/CS202210140#CS202210140_465) >
[CS202210140_23](https://purl.brain-bican.org/taxonomy/CS202210140#CS202210140_23)

---


**Labelset:** Cluster (Rank: 1)

**Parent Cell Set:** Vascular ([CS202210140_465](https://purl.brain-bican.org/taxonomy/CS202210140#CS202210140_465))



**Cell Ontology Term:**  pericyte ([CL:0000669](https://www.ebi.ac.uk/ols/ontologies/cl/terms?obo_id=CL:0000669)) 

**Rationale:** Inferred from expression of: RGS5 (Cho et al., 2003);  PDGFRB, ANPEP (in a subset) (Sweeney et al., 2016); MYH11, MYOCD, CNN1, NG2 / CSPG4 (Kumar et al., 2017).   For example, the absence of α‐smooth muscle actin (SMA) on NG2‐positive cells in CNS capillaries has led some workers to the erroneous conclusion that NG2 is expressed by endothelial cells, rather than mural cells, in this microvasculature (Schrappe et al., 1991; Grako and Stallcup, 1995). Our current results demonstrate that, although SMA is an excellent marker for smooth muscle cells, it is not always an appropriate marker for pericytes in vivo. (Ozerdem et al., 2001)

| Rationale DOIs |
|----------------|
|https://doi.org/10.1096/fj.02-0340fje|
|https://doi.org/10.1038/nn.4288|
|https://doi.org/10.1016/j.celrep.2017.05.019|

[MARKER GENES.]: #


| Marker Genes |
|--------------|
|PDGFRB|
|CSPG4|

---

[TRANSFERRED ANNOTATIONS.]: #


**Transferred annotations:**

| Transferred cell label | Source taxonomy | Source node accession | Algorithm name | Comment |
|------------------------|-----------------|-----------------------|----------------|---------|
|VLMC|https://purl.brain-bican.org/taxonomy/AIT_MTG/AIT_MTG.json|[CrossArea_subclass:f6b98fd9f4](https://purl.brain-bican.org/taxonomy/AIT_MTG#CrossArea_subclass_f6b98fd9f4)||We performed PCA (50 components) on our full dataset, trained a random forest classifier (scikit-learn, class_ weight=‘balanced’, max_depth=50) on the MTG labels, and then predicted labels for all cells. We labeled each cluster with the mode of its constituent cells if two conditions were met: more than 0.8 of predicted labels matched the mode, and the mean probability of these pre- dictions was greater than 0.8.|

[AUTHOR ANNOTATION FIELDS.]: #


**Author annotation fields:**

| Author annotation | Value |
|-------------------|-------|
|Cluster ID|22|
|Class auto_annotation|PER|
|Neurotransmitter auto_annotation|None|
|Neuropeptide auto_annotation|IGF|
|Subtype auto_annotation|None|
|Transferred MTG Label|VLMC|
|Top three regions|Thalamus: 34.2%, Cerebral cortex: 15.9%, Basal forebrain: 10.2%|
|Top three dissections|Human CBV: 6.7%, Human CM: 5.4%, Human LP: 5.3%|
|Top Enriched Genes|CARMN, NOTCH3, SLC6A12, ITIH5, GGT5, SLC12A7, IFITM2, LINC02147, CYSLTR2, BGN|
|Number of cells|1856.0|
|DoubletFinder score|0.029533909|
|Total UMI|3559.655711|
|Fraction unspliced|0.607943216|
|Fraction mitochondrial|0.01293205|
|H19.30.002|634.0|
|H19.30.001|345.0|
|H18.30.002|868.0|
|H18.30.001|9.0|
|Fraction cells from top donor|0.467672414|
|Number of donors|4.0|
|subcluster_id|None|
